medical treatment of amblyopia: present state and perspectives

Clicks: 153
ID: 178071
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #145 of 231 articles by views in planta medica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 231 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A brief review is provided on the role of experimental modulation of the visual system during its plastic period. The importance of several substances could be demonstrated. Potential clinical applications of available studies for amblyopia treatment are summarised. The role of the dopaminergic system and particularly of dopamine in amblyopia are also discussed. Results of the use of cytidin-5’-diphosphocoline (citicoline) in amblyopia are evaluated in detail. Advantages and indications for a combination of citicoline with part-time occlusion are discussed in detail. Finally, new administration modalities of citicoline, more detailed evaluation of its efficacy and the use of new substances are briefly analysed.
Reference Key
campos2012zdravnikimedical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Emilio C. Campos;Michela Fresina
Journal planta medica
Year 2012
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.